DanCann Pharma A/S

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: DK0061410487

DKK

0.44

-0.05 (-9.39%)

Dec 04

SAT

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

New Nordic Healthbrands AB

Midsona AB

BioGaia AB

Wntresearch AB

DanCann Pharma A/S

Eevia Health Plc

Hemply Balance Holding AB

Why is DanCann Pharma A/S ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

54.04%

EBIT Growth (5y)

4.73%

EBIT to Interest (avg)

-6.88

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.24

Sales to Capital Employed (avg)

0.50

Tax Ratio

0.66%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.09

EV to EBIT

-0.10

EV to EBITDA

-0.12

EV to Capital Employed

0.10

EV to Sales

0.19

PEG Ratio

Dividend Yield

ROCE (Latest)

-102.91%

ROE (Latest)

-122.04%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for DanCann Pharma A/S

Net Profit

Higher at DKK -5.01 MM

than preceding 12 month period ended Dec 2024

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (DKK MM)

Operating Cash Flow

Highest at DKK -5.24 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (DKK MM)

Debt-Equity Ratio

Lowest at -23.76 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 20.54%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales

Higher at DKK 7.06 MM

than preceding 12 month period ended Dec 2024

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (DKK MM)

Raw Material Cost

Fallen by -22.59% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for DanCann Pharma A/S

Inventory Turnover Ratio

Lowest at 42.36%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio